Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos(New York University), Aristotelis Tsirigos(IBM Research - Thomas J. Watson Research Center), Pieter Van Vlierberghe(Columbia University Irving Medical Center), Jelena Nedjic(Howard Hughes Medical Institute), Thomas Trimarchi(Howard Hughes Medical Institute), Maria Sol Flaherty(Cancer Genetics (United States)), Dolors Ferrés-Marcó(Consejo Superior de Investigaciones Científicas), Vanina G. Da Ros(Consejo Superior de Investigaciones Científicas), Zuojian Tang(New York University), Jasmin Siegle(New York University), Patrik Asp(New York University), Michael Hadler(Cancer Genetics (United States)), Isaura Rigo(Cancer Genetics (United States)), Kim De Keersmaecker(Vlaams Instituut voor Biotechnologie), Jay Patel(Memorial Sloan Kettering Cancer Center), Toan Huynh(IBM Research - Thomas J. Watson Research Center), Filippo Utro(IBM Research - Thomas J. Watson Research Center), Sandrine Poglio(Inserm), Jeremy B. Samon(Cancer Genetics (United States)), Elisabeth Paietta(Montefiore Medical Center), Janis Racevskis(Montefiore Medical Center), Jacob M. Rowe(Rambam Health Care Campus), Raúl Rabadán(Columbia University), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Stuart M. Brown(New York University), Françoise Pflumio(Inserm), María Domínguez(Consejo Superior de Investigaciones Científicas), Adolfo A. Ferrando(Cancer Genetics (United States)), Iannis Aifantis(Howard Hughes Medical Institute)
Cited by 526Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis